Navidea Biopharmaceuticals Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Navidea Biopharmaceutica last-minute Real Value cannot be determined due to lack of data. The latest price of Navidea Biopharmaceutica is $0.0. Our model forecasts the value of Navidea Biopharmaceutica from analyzing the firm fundamentals such as Current Valuation of 3.5 M, return on equity of -11.0, and Shares Owned By Insiders of 35.43 % as well as examining its technical indicators and probability of bankruptcy.
Navidea Biopharmaceutica Total Value Analysis
Navidea Biopharmaceuticals is now anticipated to have valuation of 3.5 M with market capitalization of 8.04 M, debt of 2.43 M, and cash on hands of 328.01 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Navidea Biopharmaceutica fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
3.5 M | 8.04 M | 2.43 M | 328.01 K |
Navidea Biopharmaceutica Investor Information
About 35.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.39. Navidea Biopharmaceutica last dividend was issued on the 26th of April 2019. The entity had 1:20 split on the 26th of April 2019. Based on the key measurements obtained from Navidea Biopharmaceutica's financial statements, Navidea Biopharmaceuticals is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Navidea Biopharmaceutica Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Navidea Biopharmaceutica has an asset utilization ratio of 1.5 percent. This suggests that the Company is making $0.015 for each dollar of assets. An increasing asset utilization means that Navidea Biopharmaceuticals is more efficient with each dollar of assets it utilizes for everyday operations.Navidea Biopharmaceutica Ownership Allocation
Navidea Biopharmaceutica maintains a total of 100.08 Million outstanding shares. Navidea Biopharmaceuticals holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.Navidea Biopharmaceutica Profitability Analysis
The company reported the previous year's revenue of 65.65 K. Net Loss for the year was (15.18 M) with loss before overhead, payroll, taxes, and interest of (119.3 K).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Navidea Biopharmaceutica's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Navidea Biopharmaceutica and how it compares across the competition.
Navidea Biopharmaceutica Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 29.3 M |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Other Consideration for investing in Navidea Pink Sheet
If you are still planning to invest in Navidea Biopharmaceutica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Navidea Biopharmaceutica's history and understand the potential risks before investing.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |